Identification of a clinical signature predictive of differentiation fate of human bone marrow stromal cells.

Using a combination of clinical and cellular criteria, it is possible to predict differentiation outcome of hBMSCs. This signature may be helpful in selecting donor cells in clinical trials of bone regeneration.